Alyeska Investment Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.55M | Buy |
125,000
+25,000
| +25% | +$710K | 0.01% | 446 |
|
|
2025
Q1 | $2.95M | Buy |
100,000
+50,000
| +100% | +$1.48M | 0.01% | 394 |
|
|
2024
Q4 | $1.45M | Sell |
50,000
-25,000
| -33% | -$727K | 0.01% | 477 |
|
|
2024
Q3 | $3.44M | Sell |
75,000
-75,000
| -50% | -$3.44M | 0.02% | 383 |
|
|
2024
Q2 | $6.13M | Buy |
+150,000
| New | +$6.13M | 0.04% | 312 |
|
|
2020
Q4 | – | Sell |
-113,527
| Closed | -$3.2M | – | 583 |
|
|
2020
Q3 | $3.2M | Sell |
113,527
-133,300
| -54% | -$3.75M | 0.05% | 300 |
|
|
2020
Q2 | $6.98M | Buy |
+246,827
| New | +$6.98M | 0.11% | 227 |
|